(Q37783196)

23 August 2017

1 reference

title

Newer ACE inhibitors. A look at the future (English)

1 reference

23 August 2017

Salvetti A

1

1 reference

23 August 2017

publication date

1 December 1990

1 reference

23 August 2017

1 reference

23 August 2017

volume

40

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

800-828

1 reference

Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs

23 August 2017

cites work

1 reference

12 December 2020

Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (delapril) in patients with deteriorated kidney function and in normal control subjects

1 reference

12 December 2020

Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension

1 reference

12 December 2020

Relative efficacy of vasodilator therapy in chronic congestive heart failure. Implications of randomized trials.

1 reference

12 December 2020

Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects

1 reference

12 December 2020

Comparison of captopril and enalapril in patients with severe chronic heart failure

1 reference

12 December 2020

The future of angiotensin-converting enzyme inhibitors.

1 reference

12 December 2020

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

1 reference

12 December 2020

Intracardiac generation of angiotensin and its physiologic role.

1 reference

12 December 2020

Clinical pharmacology of ramipril

1 reference

12 December 2020

Medical intelligence drug therapy: captopril

1 reference

12 December 2020

Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Pharmacologic, metabolic, and toxicologic profile of spirapril (SCH 33844), a new angiotensin converting inhibitor.

1 reference

12 December 2020

Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).

1 reference

12 December 2020

Quinapril and blood lipids

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors: past, present, and bright future

1 reference

12 December 2020

The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases

1 reference

12 December 2020

Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states.

1 reference

12 December 2020

Vascular wall renin in spontaneously hypertensive rats. Potential relevance to hypertension maintenance and antihypertensive effect of captopril

1 reference

12 December 2020

Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of food on the bioavailability of captopril in healthy subjects

1 reference

12 December 2020

Pharmacokinetics and acute effect on the renin-angiotensin system of delapril in patients with chronic renal failure.

1 reference

12 December 2020

Regulation of regional vascular tone: the role of angiotensin conversion in human forearm resistance vessels.

1 reference

12 December 2020

Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928

1 reference

12 December 2020

Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers

1 reference

12 December 2020

Significance of the vascular renin-angiotensin pathway

1 reference

12 December 2020

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 reference

12 December 2020

Release of a Prostaglandin E-Like Substance from Canine Kidney by Bradykinin

1 reference

12 December 2020

Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors

1 reference

12 December 2020

Acute dose-response curve of enalapril in renovascular hypertensives

1 reference

12 December 2020

Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders

1 reference

12 December 2020

Influence of renal function on the pharmacokinetics of ramipril (HOE 498)

1 reference

12 December 2020

Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers

1 reference

12 December 2020

Perindopril, a new angiotensin converting enzyme inhibitor--clinical pharmacological studies in healthy subjects

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist

1 reference

12 December 2020

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

1 reference

12 December 2020

Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart

1 reference

12 December 2020

Short- and long-term effects of ramipril in hypertension.

1 reference

12 December 2020

Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.

1 reference

12 December 2020

Angiotensin converting enzyme inhibitory activity of SCH 33844 (spirapril) in rats, dogs and monkeys

1 reference

12 December 2020

Combined treatment of severe essential hypertension with the new angiotensin converting enzyme inhibitor ramipril

1 reference

12 December 2020

Regression of left ventricular hypertrophy under ramipril treatment investigated by nuclear magnetic resonance imaging

1 reference

12 December 2020

Disposition of fosinopril sodium in healthy subjects

1 reference

12 December 2020

Effects on autonomic function of a new angiotensin converting enzyme inhibitor, ramipril

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors: accomplishments and challenges

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat

1 reference

12 December 2020

Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.

1 reference

12 December 2020

Comparison of acute hemodynamic effects of MC-838, a new angiotensin-converting enzyme inhibitor, with captopril in anesthetized dogs.

1 reference

12 December 2020

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers

1 reference

12 December 2020

Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats.

1 reference

12 December 2020

Influence of food on acute and chronic effects of captopril in essential hypertensive patients.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

1 reference

12 December 2020

Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.

1 reference

12 December 2020

The present molecules of converting enzyme inhibitors

1 reference

12 December 2020

Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important

1 reference

12 December 2020

Circulating and tissue angiotensin systems

1 reference

12 December 2020

Circulating versus local renin-angiotensin system in cardiovascular homeostasis.

1 reference

12 December 2020

Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats

1 reference

12 December 2020

Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications

1 reference

12 December 2020

Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension

1 reference

12 December 2020

Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril

1 reference

12 December 2020

The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421

1 reference

12 December 2020

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1 reference

12 December 2020

Review of the Overall Experience of Captopril in Hypertension

1 reference

12 December 2020

Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly.

1 reference

12 December 2020

Clinical pharmacology of enalapril

1 reference

12 December 2020

Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.

1 reference

12 December 2020

The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors in the treatment of mild to moderate essential hypertension

1 reference

12 December 2020

Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?

1 reference

12 December 2020

Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients

1 reference

12 December 2020

Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique.

1 reference

12 December 2020

Disposition and metabolism of the novel antihypertensive agent alacepril in rats

1 reference

12 December 2020

Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors

1 reference

12 December 2020

ACE inhibition for the failing heart: experience with captopril

1 reference

12 December 2020

Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of ramipril in renal failure

1 reference

12 December 2020

Steady-state kinetics of ramipril in renal failure

1 reference

12 December 2020

Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs

1 reference

12 December 2020

Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors. Emerging differences and new compounds

1 reference

12 December 2020

An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.

1 reference

12 December 2020

The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man

1 reference

12 December 2020

Hemodynamic effects of a new angiotensin converting enzyme inhibitor, spirapril, in sodium-loaded and sodium-depleted rabbits.

1 reference

12 December 2020

Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.

1 reference

12 December 2020

Pharmacokinetics of ramipril in the elderly

1 reference

12 December 2020

Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.

1 reference

12 December 2020

The antihypertensive effect of captopril. Evidence for an influence of kinins

1 reference

12 December 2020

Blood vessel-hormone interactions: angiotensin, bradykinin, and prostaglandins

1 reference

12 December 2020

Cough associated with angiotensin converting enzyme inhibition.

1 reference

12 December 2020

Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors in hypertension: a review

1 reference

12 December 2020

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Multiple-dose cimetidine administration does not influence the single-dose pharmacokinetics of quinapril and its active metabolite (CI-928)

1 reference

12 December 2020

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

12 December 2020

Pharmacokinetic interaction study with ramipril and digoxin in healthy volunteers

1 reference

12 December 2020

The influence of food on the pharmacokinetics and ACE inhibition of cilazapril

1 reference

12 December 2020

Antihypertensive activity of SCH 31846, a non-sulfhydryl angiotensin-converting enzyme inhibitor.

1 reference

12 December 2020

A need for new converting enzyme inhibitors?

1 reference

12 December 2020

Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography

1 reference

12 December 2020

Pharmacokinetics and depressor effect of delapril in patients with essential hypertension

1 reference

12 December 2020

Indomethacin reduces the antihypertensive action of enalapril

1 reference

12 December 2020

New approaches to the study of the cellular biology of the cardiovascular system.

1 reference

12 December 2020

Converting enzyme inhibitors and the cardiovascular system.

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibitory Activity of SCH 31846, a New Non-Sulfhydryl Inhibitor

1 reference

12 December 2020

Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation

1 reference

12 December 2020

Pilot Study of the Effects of the Angiotensin-Converting Enzyme Inhibitor CI-906 on Patients with Essential Hypertension

1 reference

12 December 2020

Effects of spiraprilic acid, an angiotensin converting enzyme inhibitor, on large artery compliance in anesthetized dogs.

1 reference

12 December 2020

Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers

1 reference

12 December 2020

What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.

1 reference

12 December 2020

Characterization of angiotensin converting enzyme from rat tissue by radio-inhibitor binding studies

1 reference

12 December 2020

Local generation and release of angiotensin II in peripheral vascular tissue

1 reference

12 December 2020

Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat.

1 reference

12 December 2020

1 reference

12 December 2020

Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril

1 reference

12 December 2020

Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients

1 reference

12 December 2020

Effects of angiotensin converting enzyme inhibitor, perindopril, on autonomic reflexes

1 reference

12 December 2020

Heart failure management: the impact of drug therapy on survival

1 reference

12 December 2020

The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients

1 reference

12 December 2020

Biotransformation studies of di-acid angiotensin converting enzyme inhibitors.

1 reference

12 December 2020

Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats

1 reference

12 December 2020

Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension

1 reference

12 December 2020

Protective effect of angiotensin converting enzyme inhibitors (CEI): captopril and perindopril on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion in rat

1 reference

12 December 2020

The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension

1 reference

12 December 2020

Ramipril: review of pharmacology

1 reference

12 December 2020

Chronic dose-response curve of enalapril in essential hypertensives. An Italian multicenter study

1 reference

12 December 2020

Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.

1 reference

12 December 2020

Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422

1 reference

12 December 2020

10.2165/00003495-199040060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

1013137419

0 references

1 reference